Clinical Trials Browser

Interventional × Head and Neck Neoplasms × Premedication × Clear all

NCT00216138 2011-05-02

Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck

Phase 2 Terminated

Head and Neck Neoplasms